Investors & Owners
The current shareholder structure at Marinomed is as follows: the founders and management team of Marinomed are the core shareholders with around 27% of total shares. The shares of the long-term investor Acropora Beteiligungs GmbH in Liquidation have been taken over by its shareholders in equal parts (as per announcement on May 30, 2023). Approximately 63.5% of shares are in free float.
Marinomed is supported by several public funding bodies, including:
Österreichische Forschungsförderungs GmbH (FFG)
Austria Wirtschaftsservice GmbH (AWS)
Stephanie Kniep, Dipl.-Ök.
Head of Investor Relations